Eye Health News and Research

Latest Eye Health News and Research

Mount Sinai receives $500,000 SU2C grant to identify therapeutic combinations for KRAS-mutant lung cancers

Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.

9 Aug 2022

WVU professor receives $1.6 million to expand research on brain circuits

A fruit fly walks on a rolling ball. As it meanders, Kevin Daly, biology professor at West Virginia University, looks deep into its brain through a specialized microscope.

9 Aug 2022

Research reveals a gut-brain pathway that contributes to the development of Alzheimer’s disease

Research led by Drs. Yuhai Zhao and Walter J Lukiw at the LSU Health New Orleans Neuroscience Center and the Departments of Cell Biology and Anatomy, Neurology and Ophthalmology, reports for the first time a pathway that begins in the gut and ends with a potent pro-inflammatory toxin in brain cells contributing to the development of Alzheimer's disease (AD).

9 Aug 2022

NIH researchers develop three-dimensional structure of twinkle protein

Researchers from the National Institutes of Health have developed a three-dimensional structure that allows them to see how and where disease mutations on the twinkle protein can lead to mitochondrial diseases.

5 Aug 2022

Vascular dysfunction may be the cause of metabolic changes that can lead to diabetes, study suggests

A major risk factor for diabetes, insulin resistance occurs when the cells of the body do not respond to insulin and cannot make use of the glucose (sugar) in the blood stream.

5 Aug 2022

KAIST researchers engineer a bacterial strain capable of producing lutein

A research group at KAIST has engineered a bacterial strain capable of producing lutein. The research team applied systems metabolic engineering strategies, including substrate channeling and electron channeling, to enhance the production of lutein in an engineered Escherichia coli strain.

4 Aug 2022

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

In a potential game changer for patients with type 2 diabetes, a team of researchers at the Diabetes, Obesity, and Metabolism Institute (DOMI) at the Icahn School of Medicine at Mount Sinai has identified a therapeutic target for the preservation and regeneration of beta cells (β cells) - cells in the pancreas that produce and distribute insulin.

4 Aug 2022

New hydrogel treatment disrupts cavity-forming biofilms and whitens teeth

The first thing people notice when they meet you is your smile. To be more confident when giving wide-mouthed, eye-crinkling smiles, people want healthy, pearly white teeth.

3 Aug 2022

Inexpensive, self-driven microfluidic chip rapidly detects Hepatitis C virus in about 45 minutes

Hepatitis C affects more than 354 million people worldwide. About 75 to 85 percent of people who have it get a long-term infection referred to as chronic Hepatitis C. Left untreated, it could lead to cirrhosis, liver cancer or liver failure.

3 Aug 2022

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

A team of US-based scientists has described the therapeutic efficacy of a pan-Orthopoxvirus inhibitor, tecovirimat, in patients with monkeypox infection

3 Aug 2022

How effective is the recommendation of wearing glasses to protect against SARS-CoV-2 and other respiratory virus infection?

Researchers tested the effectiveness of wearing glasses in lowering the risk of contracting SARS-CoV-2 and other respiratory viral infections in community backdrop.

3 Aug 2022

Study suggests an approach for promoting more equitable interpersonal treatment

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Eye Health News and Research

Latest Eye Health News and Research

Mount Sinai receives $500,000 SU2C grant to identify therapeutic combinations for KRAS-mutant lung cancers

WVU professor receives $1.6 million to expand research on brain circuits

Research reveals a gut-brain pathway that contributes to the development of Alzheimer’s disease

NIH researchers develop three-dimensional structure of twinkle protein

Vascular dysfunction may be the cause of metabolic changes that can lead to diabetes, study suggests

KAIST researchers engineer a bacterial strain capable of producing lutein

Discovery could prevent insulin resistance and have significant benefits for people with type 2 diabetes

New hydrogel treatment disrupts cavity-forming biofilms and whitens teeth

Inexpensive, self-driven microfluidic chip rapidly detects Hepatitis C virus in about 45 minutes

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

How effective is the recommendation of wearing glasses to protect against SARS-CoV-2 and other respiratory virus infection?

Study suggests an approach for promoting more equitable interpersonal treatment

Mice study shows how working memory is maintained across interconnected brain regions

Light-activated proteins can help normalize dysfunction within cells, study shows

New, non-invasive imaging method may help detect an early indicator of glaucoma

Symptoms of monkeypox differ from previous outbreaks

The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

Study shows the link between common viruses and onset of Alzheimer’s disease

Long periods in space can make bones age prematurely by up to ten years

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

Genetics & Genomics - Second Edition eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in